VIMOVO - 0186-0520-06 - (naproxen and esomeprazole magnesium)

Alphabetical Index


Drug Information of VIMOVO

Product NDC: 0186-0520
Proprietary Name: VIMOVO
Non Proprietary Name: naproxen and esomeprazole magnesium
Active Ingredient(s): 20; 500    mg/1; mg/1 & nbsp;   naproxen and esomeprazole magnesium
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of VIMOVO

Product NDC: 0186-0520
Labeler Name: AstraZeneca LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022511
Marketing Category: NDA
Start Marketing Date: 20100706

Package Information of VIMOVO

Package NDC: 0186-0520-06
Package Description: 6 TABLET, DELAYED RELEASE in 1 BOTTLE (0186-0520-06)

NDC Information of VIMOVO

NDC Code 0186-0520-06
Proprietary Name VIMOVO
Package Description 6 TABLET, DELAYED RELEASE in 1 BOTTLE (0186-0520-06)
Product NDC 0186-0520
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name naproxen and esomeprazole magnesium
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20100706
Marketing Category Name NDA
Labeler Name AstraZeneca LP
Substance Name ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Strength Number 20; 500
Strength Unit mg/1; mg/1
Pharmaceutical Classes Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]

Complete Information of VIMOVO


General Information